Bioremedix Biotechnology

Bioremedix Biotechnology is a Turkish biotechnology company founded in Izmir in 2022. According to its own materials, it focuses on developing innovative and high-technology solutions in the fields of biotechnology, immunology and biology, using scientific methods and current technological developments to offer biotechnological products and services that contribute to human health and the environment. The company states that its goal is to produce solutions that increase quality of life and promote sustainability, and that its expert team works across sectors including food, health, environment and industrial biotechnology. The company's public product line spans diagnostics, immune-support formulations and skincare. Its flagship diagnostic offering is the NAGA Rapid Test Kit, a rapid test that measures the activity of the enzyme Nagalase in serum or plasma; the company presents elevated Nagalase levels as being associated with cancer, viral infection, autoimmune diseases and autism, and markets the test on the basis of fast results (15–20 minutes), ease of use, low cost, no requirement for laboratory equipment and minimal sample volume. Its immune-related products include Glycofam Spray, described as a colostrum-based immunoglobulin and glycoprotein formula intended to trigger the immune system and activate macrophages, and CreaMaf, a skincare cream containing glycoprotein, immunoglobulins and other substances positioned for skin regeneration, moisturizing and anti-itching, anti-irritation, anti-eczema and anti-aging benefits. The company also lists serum controls for clinical chemistry, protein/immunology and therapeutic drug monitoring, supplied as lyophilized human serum-based controls in two levels with defined shelf life and reconstituted stability. Bioremedix presents itself as a research-driven company and highlights its scientific team, including Dr. Morteza Haghi (Ph.D. Biotechnology, M.Sc. Oncology), Tuğçe Kundakcı (M.Sc. Biochemistry, General Manager) and Dr. Zaka Abbaszade (Ph.D. Medical Biology, M.Sc. Occupational Safety, M.Sc. Biomedical Sciences), and links to their ResearchGate profiles. The company states on its website that it does not have dealers anywhere else, indicating a direct-sales posture rather than a broad distributor network. It is a private company headquartered in Izmir, Turkey, and its operating market as presented in its own materials is Turkey.

Bioremedix Biotechnology was founded in Izmir, Turkey, in 2022. From its inception, the company has described itself as focused on developing innovative and high-technology solutions in biotechnology, immunology and biology, applying scientific methods and the latest technological developments to create biotechnological products and services that contribute to human health and the environment. Its stated goal is to produce solutions that increase quality of life and promote sustainability, and it says its expert team works across food, health, environment and industrial biotechnology. The company's early public identity centers on a small, focused product portfolio. Its flagship diagnostic product is the NAGA Rapid Test Kit, a rapid test that measures the activity of the enzyme Nagalase in serum or plasma. Bioremedix presents elevated Nagalase levels as being associated with cancer, viral infection, autoimmune diseases and autism, and markets the test on the basis of fast results (15–20 minutes), ease of use, low cost, no requirement for laboratory equipment and minimal sample volume. Alongside the diagnostic, the company offers immune-related and skincare products: Glycofam Spray, described as a colostrum-based immunoglobulin and glycoprotein formula intended to trigger the immune system and activate macrophages, and CreaMaf, a skincare cream containing glycoprotein, immunoglobulins and other substances positioned for skin regeneration, moisturizing and anti-itching, anti-irritation, anti-eczema and anti-aging benefits. It also lists serum controls for clinical chemistry, protein/immunology and therapeutic drug monitoring, supplied as lyophilized human serum-based controls in two levels with defined shelf life and reconstituted stability. Bioremedix highlights its scientific team on its website, including Dr. Morteza Haghi (Ph.D. Biotechnology, M.Sc. Oncology), Tuğçe Kundakcı (M.Sc. Biochemistry, General Manager) and Dr. Zaka Abbaszade (Ph.D. Medical Biology, M.Sc. Occupational Safety, M.Sc. Biomedical Sciences), and links to their ResearchGate profiles. The company states on its website that it does not have dealers anywhere else, indicating a direct-sales posture rather than a broad distributor network. It is a private company headquartered in Izmir, Turkey, and its operating market as presented in its own materials is Turkey.

• 2022

  Bioremedix Biotechnology founded in Izmir, Turkey.

Research-driven biotechnology company developing immunology-based diagnostics, immune-support formulations and skincare, with a direct-sales model in Turkey.

• NAGA Rapid Test Kit

  Rapid test measuring Nagalase enzyme activity in serum or plasma; marketed for fast results (15–20 minutes), ease of use, low cost, no laboratory equipment requirement and minimal sample volume.

• Glycofam Spray

  Colostrum-based immunoglobulin and glycoprotein formula intended to trigger the immune system and activate macrophages.

• CreaMaf Skincare Cream

  Skincare cream containing glycoprotein, immunoglobulins and other substances, positioned for skin regeneration, moisturizing and anti-itching, anti-irritation, anti-eczema and anti-aging benefits.

• Serum Controls

  Lyophilized human serum-based controls in two levels for clinical chemistry, protein/immunology and therapeutic drug monitoring, with defined shelf life and reconstituted stability.

1. 1Bioremedix – biotechnologybioremedix.com
2. 2About – Bioremedix – biotechnologybioremedix.com
3. 3Serum Controls – Bioremedix – biotechnologybioremedix.com
4. 4Bioremedix Biotechnology (Turkiye) – Wikidatawikidata.org